{"entity":{"type":"insider","cik":"0001767584","url":"/insider/0001767584","json_url":"/insider/0001767584.json","name":"Lu Hongbo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2019-04-24","last":"2026-05-14","span_basis":"filed_date"},"name_variants":[{"name":"Lu Hongbo","source":"filing","n_filings":13,"first_seen":"2019-04-24","last_seen":"2026-05-14"}],"transactions":[{"id":5767514,"accession":"0001767584-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001767584-26-000002","line_url":"/filing/0001767584-26-000002#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2970.0,"shares_display":"2,970","price_per_share":76.88,"price_display":"76.88","price_state":"stated","total_value":228333.6,"total_display":"228,333.60","total_whole":"228,334","shares_owned_after":52012.0,"shares_owned_after_display":"52,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-14","scope":"insider"},{"id":6150927,"accession":"0001104659-26-037865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-037865","line_url":"/filing/0001104659-26-037865#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":422968.0,"shares_owned_after_display":"422,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-03-31","scope":"insider"},{"id":5903547,"accession":"0001104659-26-039240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-039240","line_url":"/filing/0001104659-26-039240#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3768.0,"shares_display":"3,768","price_per_share":18.63,"price_display":"18.63","price_state":"stated","total_value":70197.84,"total_display":"70,197.84","total_whole":"70,198","shares_owned_after":426736.0,"shares_owned_after_display":"426,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-02","scope":"insider"},{"id":5903461,"accession":"0001104659-26-015387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-015387","line_url":"/filing/0001104659-26-015387#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25985.0,"shares_display":"25,985","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":584662.5,"total_display":"584,662.50","total_whole":"584,663","shares_owned_after":347968.0,"shares_owned_after_display":"347,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-13","scope":"insider"},{"id":4414173,"accession":"0000919574-25-006031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-006031","line_url":"/filing/0000919574-25-006031#line-2","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":263160.0,"shares_display":"263,160","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":5000040.0,"total_display":"5,000,040.00","total_whole":"5,000,040","shares_owned_after":321983.0,"shares_owned_after_display":"321,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-09","scope":"insider"},{"id":4414165,"accession":"0000919574-25-006031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-006031","line_url":"/filing/0000919574-25-006031#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58823.0,"shares_display":"58,823","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":999991.0,"total_display":"999,991.00","total_whole":"999,991","shares_owned_after":58823.0,"shares_owned_after_display":"58,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2025-10-09","scope":"insider"},{"id":2622277,"accession":"0000919574-24-005530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-005530","line_url":"/filing/0000919574-24-005530#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58823.0,"shares_display":"58,823","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":999991.0,"total_display":"999,991.00","total_whole":"999,991","shares_owned_after":58823.0,"shares_owned_after_display":"58,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider"},{"id":2107262,"accession":"0000919574-24-005529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-005529","line_url":"/filing/0000919574-24-005529","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":476190.0,"shares_display":"476,190","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":476190.0,"shares_owned_after_display":"476,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":3098319,"accession":"0001628280-24-048162","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-24-048162","line_url":"/filing/0001628280-24-048162#line-5","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":11000.0,"total_display":"11,000.00","total_whole":"11,000","shares_owned_after":36080.0,"shares_owned_after_display":"36,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-18","filed_date":"2024-11-15","scope":"insider"},{"id":3098315,"accession":"0001628280-24-048162","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-24-048162","line_url":"/filing/0001628280-24-048162#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":35580.0,"shares_owned_after_display":"35,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-11-15","scope":"insider"},{"id":3098310,"accession":"0001628280-24-048162","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-24-048162","line_url":"/filing/0001628280-24-048162#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":27.34,"price_display":"27.34","price_state":"stated","total_value":4101.0,"total_display":"4,101.00","total_whole":"4,101","shares_owned_after":35080.0,"shares_owned_after_display":"35,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-11-15","scope":"insider"},{"id":3098304,"accession":"0001628280-24-048162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-048162","line_url":"/filing/0001628280-24-048162#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850.0,"shares_display":"850","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":23375.0,"total_display":"23,375.00","total_whole":"23,375","shares_owned_after":34930.0,"shares_owned_after_display":"34,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-11-15","scope":"insider"},{"id":3098300,"accession":"0001628280-24-048162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-048162","line_url":"/filing/0001628280-24-048162#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":11200.0,"total_display":"11,200.00","total_whole":"11,200","shares_owned_after":34080.0,"shares_owned_after_display":"34,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-22","filed_date":"2024-11-15","scope":"insider"},{"id":2048477,"accession":"0001628280-24-012327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-24-012327","line_url":"/filing/0001628280-24-012327#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":27500.0,"total_display":"27,500.00","total_whole":"27,500","shares_owned_after":33680.0,"shares_owned_after_display":"33,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-20","scope":"insider"},{"id":2048475,"accession":"0001628280-24-012327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-012327","line_url":"/filing/0001628280-24-012327#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":32680.0,"shares_owned_after_display":"32,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-20","scope":"insider"},{"id":2048472,"accession":"0001628280-24-012327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-012327","line_url":"/filing/0001628280-24-012327#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":27.49,"price_display":"27.49","price_state":"stated","total_value":27490.0,"total_display":"27,490.00","total_whole":"27,490","shares_owned_after":31680.0,"shares_owned_after_display":"31,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":6331952,"accession":"0001562180-22-008428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-008428","line_url":"/filing/0001562180-22-008428#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":758620.0,"shares_display":"758,620","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":5499995.0,"total_display":"5,499,995.00","total_whole":"5,499,995","shares_owned_after":4340212.0,"shares_owned_after_display":"4,340,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-23","scope":"insider"},{"id":6225857,"accession":"0001562180-22-006567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-006567","line_url":"/filing/0001562180-22-006567#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":2160000.0,"total_display":"2,160,000.00","total_whole":"2,160,000","shares_owned_after":3581592.0,"shares_owned_after_display":"3,581,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-08","scope":"insider"},{"id":6093004,"accession":"0001562180-22-006125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-22-006125","line_url":"/filing/0001562180-22-006125#line-3","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":3630000.0,"total_display":"3,630,000.00","total_whole":"3,630,000","shares_owned_after":2981592.0,"shares_owned_after_display":"2,981,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-16","scope":"insider"},{"id":6093001,"accession":"0001562180-22-006125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-006125","line_url":"/filing/0001562180-22-006125#line-2","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1218.0,"shares_display":"1,218","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":3641.82,"total_display":"3,641.82","total_whole":"3,642","shares_owned_after":1481592.0,"shares_owned_after_display":"1,481,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6092997,"accession":"0001562180-22-006125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-006125","line_url":"/filing/0001562180-22-006125#line-1","is_derivative":false,"issuer_cik":"0001767584","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001767584","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1123021.0,"shares_display":"1,123,021","price_per_share":2.98,"price_display":"2.98","price_state":"stated","total_value":3346602.58,"total_display":"3,346,602.58","total_whole":"3,346,603","shares_owned_after":1480374.0,"shares_owned_after_display":"1,480,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-16","scope":"insider"},{"id":8390840,"accession":"0001209191-19-025793","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-025793","line_url":"/filing/0001209191-19-025793#line-3","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001767584","owner_name":"Lu Hongbo","owner_display_name":"Lu Hongbo","owner_url":"/insider/0001767584","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":1080000.0,"total_display":"1,080,000.00","total_whole":"1,080,000","shares_owned_after":1727550.0,"shares_owned_after_display":"1,727,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-22","filed_date":"2019-04-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Director","n_filings":3,"first_seen":"2024-03-20","last_seen":"2026-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001953926","name":"Zenas BioPharma, Inc.","url":"/issuer/0001953926","role":"Director","n_filings":5,"first_seen":"2024-09-17","last_seen":"2026-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Director","n_filings":4,"first_seen":"2022-08-16","last_seen":"2024-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Director","n_filings":1,"first_seen":"2019-04-24","last_seen":"2019-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767584","retrieved_at":"2026-08-24T02:05:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}